Liangqin Tong

Liangqin Tong

Auto-generated profile, based on publicly available information

Liangqin Tong

Tsinghua-Peking Joint Center for Life Sciences, School of Medicine, Tsinghua University, Beijing, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2019 in Nature Microbiology
Verified
Journal Article
Closed access
YZYibin Zhu
Yibin Zhu
LTLiangqin Tong
Liangqin Tong
KNKaixiao Nie
Kaixiao Nie
IWItsanun Wiwatanaratanabutr
Itsanun Wiwatanaratanabutr
PSPeng Sun
Peng Sun
Gong ChengGong Cheng
Gong Cheng

17 April 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
YLYubin Liu
Yubin Liu
ZWZiyi Wang
Ziyi Wang
XZXinyu Zhuang
Xinyu Zhuang
SZShengnan Zhang
Shengnan Zhang
ZCZhicheng Chen
Zhicheng Chen
Gong ChengGong Cheng
Gong Cheng
A full understanding of the inactivated COVID-19 vaccine-mediated antibody responses to SARS-CoV-2 circulating variants will inform vaccine effectiveness and vaccination development strategies. Here, we offer insights into the inactivated vaccine-induced antibody responses after prime-boost vaccination at both the polyclonal and monoclonal levels. We characterized the VDJ sequence of 118 monoclonal antibodies (mAbs) and found that 20 neutralizing mAbs showed varied potency and breadth against a range of variants including XBB.1.5, BQ.1.1, and BN.1. Bispecific antibodies (bsAbs) based on nonoverlapping mAbs exhibited enhanced neutralizing potency and breadth against the most antibody-evasive strains, such as XBB.1.5, BQ.1.1, and BN.1. The passive transfer of mAbs or their bsAb effectively protected female hACE2 transgenic mice from challenge with an infectious Delta or Omicron BA.2 variant. The neutralization mechanisms of these antibodies were determined by structural characterization. Overall, a broad spectrum of potent and distinct neutralizing antibodies can be induced in individuals immunized with the SARS-CoV-2 inactivated vaccine BBIBP-CorV, suggesting the application potential of inactivated vaccines and these antibodies for preventing infection by SARS-CoV-2 circulating variants.

9 May 2022 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
LTLiangqin Tong
Liangqin Tong
XXXiaoping Xiao
Xiaoping Xiao
MLMin Li
Min Li
SFShisong Fang
Shisong Fang
EMEnhao Ma
Enhao Ma
Gong ChengGong Cheng
Gong Cheng

15 September 2026 in Nature Metabolism
Verified
Journal Article
Open access
PDF file
LTLiangqin Tong
Liangqin Tong
XXXiaoping Xiao
Xiaoping Xiao
MLMin Li
Min Li
SFShisong Fang
Shisong Fang
EMEnhao Ma
Enhao Ma
Gong ChengGong Cheng
Gong Cheng

30 October 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
YLYubin Liu
Yubin Liu
ZWZiyi Wang
Ziyi Wang
XZXinyu Zhuang
Xinyu Zhuang
SZShengnan Zhang
Shengnan Zhang
ZCZhicheng Chen
Zhicheng Chen
Gong ChengGong Cheng
Gong Cheng